Preclinical data show that narazaciclib treatment led to significant tumor growth inhibition, demonstrating synergy with standard-of-care ibrutinib, in ibrutinib-sensitive and -resistant settings ...
As European markets navigate a mixed landscape, with the pan-European STOXX Europe 600 Index ending slightly lower and varied performances across major indices like Germany's DAX and France's CAC 40, ...
In recent weeks, global markets have been closely watching developments in trade negotiations and monetary policy, with small- and mid-cap indexes showing resilience by posting gains for the fifth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback